Jieping Lei

Jieping Lei

Auto-generated profile, based on publicly available information

Jieping Lei

National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, People’s Republic of China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
ZZZhenguo Zhai
Zhenguo Zhai
DWDingyi Wang
Dingyi Wang
JLJieping Lei
Jieping Lei
YYYuanhua Yang
Yuanhua Yang
XXXiaomao Xu
Xiaomao Xu
CWChen Wang
Chen Wang
Similar trends of management and in-hospital mortality of acute pulmonary embolism (PE) have been reported in European and American populations. However, these tendencies are not clear in Asian countries. We retrospectively analysed the trends of risk stratification, management and in-hospital mortality for patients with acute PE through a multicentre registry in China (CURES).Adult patients with acute symptomatic PE were included between 2009 and 2015. Trends in disease diagnosis, treatment and death in hospital were fully analysed. Risk stratification was retrospectively classified by haemodynamic status and the simplified Pulmonary Embolism Severity Index (sPESI) score according to the 2014 European Society of Cardiology/European Respiratory Society guidelines.Among 7438 patients, the proportions with high (haemodynamic instability), intermediate (sPESI≥1) and low (sPESI=0) risk were 4.2%, 67.1% and 28.7%, respectively. Computed tomographic pulmonary angiography was the most widely used diagnostic approach (87.6%) and anticoagulation was the most frequently adopted initial therapy (83.7%). Between 2009 and 2015, a significant decline was observed for all-cause mortality (from 3.1% to 1.3%, adjusted pfor trend=0.0003), with a concomitant reduction in the use of initial systemic thrombolysis (from 14.8% to 5.0%, pfor trend<0.0001). The common predictors for all-cause mortality shared by haemodynamically stable and unstable patients were co-existing cancer, older age and impaired renal function.The considerable reduction of mortality over the years was accompanied by changes in initial treatment. These findings highlight the importance of risk stratification-guided management throughout the nation.

2 February 2023 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
JLJieping Lei
Jieping Lei
KHKe Huang
Ke Huang
JPJun Pan
Jun Pan
WLWei Li
Wei Li
HNHongtao Niu
Hongtao Niu
CWChen Wang
Chen Wang
Background: COPD is the most prevalent chronic respiratory disease in China. It is estimated that there is a large, as-yet undetected, high-risk population who will develop in COPD in future.Methods and design: In this context, a nationwide COPD screening programme was launched on 9 October 2021. This multistage sequential screening programme incorporates a previously validated questionnaire (i.e.COPD Screening Questionnaire) and pre- and post-bronchodilator spirometry to target the COPD high-risk population. The programme plans to recruit 800 000 participants (eligible age 35–75 years) from 160 districts or counties of 31 provinces, autonomous regions or municipalities across China. The filtered COPD high-risk population and early-detected COPD patients will receive integrated management and be followed-up for ≥1 year.Discussion: This is the first large-scale prospective study to determine the net benefit of mass screening for COPD in China. Whether the smoking cessation rate, morbidity, mortality and health status of individuals at high risk of COPD could be improved along with this systematic screening programme will be observed and validated. Moreover, the diagnostic accuracy, cost-effectiveness and superiority of the screening programme will also be assessed and discussed. The programme marks a remarkable achievement in the management of chronic respiratory disease in China.

14 July 2021 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
PDF file
JLJieping Lei
Jieping Lei
LYLulu Yang
Lulu Yang
GWGeyi Wen
Geyi Wen
SQShiwei Qumu
Shiwei Qumu
XRXiaoxia Ren
Xiaoxia Ren
TYTing Yang
Ting Yang
Introduction: The novel coronavirus disease 2019 (COVID‐19) could cause physical and psychological dysfunction in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infected patients. Pulmonary telerehabilitation is strongly recommended due to the contagious nature of the disease, but its efficacy and benefit need to be comprehensively evaluated.Methods: An 8‐week pulmonary telerehabilitation programme is designed in a real‐world and prospective manner, aiming to assess the efficacy of remote rehabilitation among discharged patients with COVID‐19 from three designated hospitals in the epicenter of China (Wuhan City). The telerehabilitation programme includes physicians and physiotherapists remotely guided training (online) for 2 weeks, and patient self‐managed rehabilitation (offline) for 6 weeks with assistance of information technology and digital device. The main rehabilitation intervention includes breathing exercise, respiratory muscle training, aerobic exercise, and resistance training. The primary outcome is 6‐min walk distance, and secondly pulmonary function, respiratory muscle strength, physical activity, symptom, psychological status and quality of life, etc. will also be assessed. Patients will be followed up periodically at week two, four, eight after enrolment and at month one, three, six and 12 after the rehabilitation accomplished, respectively. Current study has been approved by the ethics committee of China‐Japan Friendship Hospital and three participating centers in Wuhan City.Discussion: We anticipate that the health status of discharged patients with COVID‐19 could be improved through this systemic pulmonary telerehabilitation programme. The interdisciplinary remote mode of rehabilitation could be an optimal way in management of emerging respiratory tract infectious disease.Trial registration: ClinicalTrials.gov, NCT04368793.

2 March 2020 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
DWDingyi Wang
Dingyi Wang
SXShao Xiang
Shao Xiang
JLJieping Lei
Jieping Lei
ZZZhenguo Zhai
Zhenguo Zhai

27 April 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MSMinghui Shi
Minghui Shi
SQShiwei Qumu
Shiwei Qumu
XBXiaoning Bu
Xiaoning Bu
JZJie Zhang
Jie Zhang
KLKai Liu
Kai Liu
KHKe Huang
Ke Huang
Background: Pulmonary rehabilitation (PR) is a cornerstone for the management of chronic obstructive pulmonary disease (COPD), yet global uptake remains low due to geographic and resource barriers. Digital health technologies, specifically smartphone apps, offer a promising platform for delivering accessible home-based PR. In addition, music-assisted interventions not only offer unique physiological and psychological benefits but may also serve as an innovative approach to enhancing patient engagement and improving the effectiveness of rehabilitation in home settings. Objective: This study aimed to evaluate the effectiveness of a smartphone app–based, music-facilitated multicomponent PR program (integrating rhythm-guided walking [RW] and singing) for improving exercise capacity and other clinical outcomes in patients with COPD compared with usual care (UC). Methods: This 3-arm, parallel-group, multicenter randomized controlled trial included 70 participants in China. Participants were randomized into a multimodule training (MT) group, which included a multicomponent PR program integrating RW and singing training (n=25); a RW group, which included RW training (n=23); or a UC group (n=22). The MT and RW groups received 12-week asynchronous home-based training via a smartphone app, and all arms received structured patient education. The primary outcome was the distance achieved in the incremental shuttle walking test (ISWT) at 12 weeks. The secondary outcomes included dyspnea, quality of life, and pulmonary function. Results: The modified intention-to-treat principle was used to analyze the 70 study patients. At 12 weeks, the ISWT distance was significantly greater in the MT group than in the UC group (mean difference [MD] 56.35 m, 95% CI 6.66-106.04 m; P =.03; Cohen d =0.30). Significant improvements were observed in the MT group compared with the UC group in the modified Medical Research Council dyspnea scale (mMRC) score (MD −0.44, 95% CI −0.80 to −0.08; P =.02), COPD Assessment Test score (MD −3.23, 95% CI −6.18 to −0.29; P =.03), Hospital Anxiety and Depression Scale-anxiety subscale score (MD −2.31, 95% CI −3.99 to −0.63; P =.008), and inspiratory capacity (MD 15.98% predicted, 95% CI 4.76 to 27.21; P =.01). However, no significant differences were found between the RW and UC groups in primary or secondary outcomes. Compared with RW, MT was significantly better at decreasing the mMRC score ( P =.03). Conclusions: The findings of this study demonstrate that our smartphone app–based music-facilitated multicomponent PR program (including tempo-guided walking and singing) caused clinically meaningful improvements in exercise capacity among patients with COPD compared to UC. Moreover, secondary outcomes, including dyspnea, quality of life, psychological status, and inspiratory capacity, showed better improvements with MT than with UC.

7 September 2026 in Chinese Medical Journal Pulmonary and Critical Care Medicine
Verified
Journal Article
Open access
SWSinan Wu
Sinan Wu
JKJian Kang
Jian Kang
XZXiangyan Zhang
Xiangyan Zhang
LYLan Yang
Lan Yang
FWFuqiang Wen
Fuqiang Wen
JLJieping Lei
Jieping Lei